Finally Chris over at Ouroboros came up with the idea and the quick implementation of Hourglass, a blog carnival devoted to the biology of aging/biogerontology. For some reason I am not an explicit supporter of blog carnivals – many of my posts were chosen by carnival editors but I never hosted one -, but Hourglass… Continue reading Hourglass, a blog carnival devoted to the biology of aging
The concept of decellularizing complex organs in cadavers and reseeding the remaining matrix structure with differentiated, stem or progenitor cells, growing in a bioreactor and transplanting back to the organism could turn out to be a real technological shortcut in the field of tissue engineering. It is not a brand new story on the web,… Continue reading The decellularized matrix hack: skipping many steps in tissue engineering
Bill Dye has a serious muscle-tendon damage and is looking for an experimental regenerative medicine therapy (stem cells or tissue engineering or both) after 2 years and many surgical interventions. If any out of the expert readers of this blog can help or knows someone, who can help, please do comment or email Mr. Bill… Continue reading Bill Dye’s hope for an early regenerative medicine therapy! Please help.
UK scientists in artificial skin breakthrough: “A long-lasting artificial skin has been developed by British researchers. The Cambridge-based Intercytex Group Plc has announced that tests had produced promising results in healing wounds in early clinical trials…. ICX-SKN is created from a matrix produced by the same skin cells that are responsible for synthesising new tissue… Continue reading Off-the-shelf skin replacements are on their way…
Positively tuned (for the most part) report on stem cell science by Ricki Lewis: The hard cell Nature 447, 748-749 (June 2007) Excerpts, emphasis added by me: research in the field is thriving globally. At least 500 companies and collaborations have sprung up, 100 of them in the past year alone… A solid background for… Continue reading Industry and career focused stem cell report in the current Nature volume
In the age of compelling technology analogies and nomenclatures it was unavoidable that somebody at last identifies enough differences in the history of industrial regenerative medicine to tell Regenerative Medicine 1.0 from 2.0. The man behind is Chris Mason, Group Leader of Stem Cell + Regenerative Medicine Bioprocessing Unit, University College London and cofounder and… Continue reading Are we really in the age of Regenerative Medicine 2.0? A comparison by Chris Mason
Dr. Anthony Atala of pluripotent amniotic fluid-derived stem cell and tissue engineered bladder fame gave a presentation on Regenerative Medicine at the 2007 New Yorker Conference “2012: Stories from the Near Future”. Atala, the director of the Biopolis-like huge Wake Forest Institute for Regenerative Medicine with circa 150 people, talks amongst others on the differences… Continue reading Anthony Atala on regenerative medicine at New Yorker’s 2012 conference